Mark S. Huberman
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 1%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 41
- Lung Cancer Diagnosis and Treatment 13
- Oncology 32
- Lung Cancer Research Studies 13
- Colorectal Cancer Treatments and Studies 5
- Co-authors
- Daniel B. Costa (36 shared papers)Susumu Kobayashi (16 shared papers)Paul A. VanderLaan (20 shared papers)Daniel G. Tenen (4 shared papers)Deepa Rangachari (18 shared papers)Balázs Halmos (5 shared papers)Eric K. Rowinsky (3 shared papers)Daniel D. Karp (4 shared papers)
- Journals
- Journal of Thoracic Oncology (14 papers)Lung Cancer (13 papers)Journal of Clinical Oncology (11 papers)Cancer (4 papers)Clinical Lung Cancer (4 papers)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Mark S. Huberman
79 papers receiving 4.5k citations
Mark S. Huberman's Hit Papers
Peers
Comparison fields: 5 of 95
- Pulmonary and Respiratory Medicine 2.9k
- Oncology 2.1k
- Cancer Research 517
- Hepatology 165
- Dermatology 162
Countries citing papers authored by Mark S. Huberman
This map shows the geographic impact of Mark S. Huberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Huberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Huberman more than expected).
Fields of papers citing papers by Mark S. Huberman
This network shows the impact of papers produced by Mark S. Huberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Huberman. The network helps show where Mark S. Huberman may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Huberman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer Hit paper breakdown → | 2004 | 893 |
| 2 | Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib Hit paper breakdown → | 2006 | 492 |
| 3 | BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations Hit paper breakdown → | 2007 | 409 |
| 4 | Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers Hit paper breakdown → | 2015 | 362 |
| 5 | 2012 | 172 | |
| 6 | 2008 | 139 | |
| 7 | 2017 | 139 | |
| 8 | 2007 | 137 | |
| 9 | 2014 | 120 | |
| 10 | 1980 | 119 | |
| 11 | 2017 | 106 | |
| 12 | 1997 | 82 | |
| 13 | 1998 | 74 | |
| 14 | 2008 | 74 | |
| 15 | 2018 | 70 | |
| 16 | 2018 | 70 | |
| 17 | 2010 | 66 | |
| 18 | 2015 | 63 | |
| 19 | 2013 | 60 | |
| 20 | 2018 | 51 |
About Mark S. Huberman
Mark S. Huberman is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Epidemiology, having authored 80 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Research Studies (13 papers), Lung Cancer Diagnosis and Treatment (13 papers), Cancer Genomics and Diagnostics (6 papers), Cancer therapeutics and mechanisms (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.9k citations), Oncology (2.1k citations), Cancer Research (517 citations), Hepatology (165 citations) and Dermatology (162 citations). Mark S. Huberman has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Daniel B. Costa, Susumu Kobayashi, Paul A. VanderLaan, Daniel G. Tenen, Deepa Rangachari, Balázs Halmos, Eric K. Rowinsky, Daniel D. Karp, P. Santabárbara and Philip Bonomi. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Journal of Clinical Oncology, Cancer and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.